BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6170290)

  • 1. Is placental function testing worthwhile? An update on placental lactogen.
    Grudzinskas JG; Gordon YB; Wadsworth J; Menabawey M; Chard T
    Aust N Z J Obstet Gynaecol; 1981 May; 21(2):103-5. PubMed ID: 6170290
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal biparietal diameter and maternal plasma concentrations of placental lactogen, chorionic gonadotrophin, oestriol, and alpha-fetoprotein in normal and pathological pregnancies.
    Persson PH; Grennert L; Gennser G; Eneroth P
    Br J Obstet Gynaecol; 1980 Jan; 87(1):25-32. PubMed ID: 6153901
    [No Abstract]   [Full Text] [Related]  

  • 3. Human placental lactogen and fetal abnormality.
    Gau G; Cadle G
    Lancet; 1974 Sep; 2(7883):775. PubMed ID: 4143030
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Human placental lactogen and fetal abnormality.
    Spellacy WN
    Lancet; 1975 Jan; 1(7898):99. PubMed ID: 46044
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Human placental lactogen and fetal abnormality.
    Gau GS
    Lancet; 1975 Feb; 1(7901):274. PubMed ID: 46413
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein.
    Grudzinskas JG; Gordon YB; Menabawey M; Lee JN; Wadsworth J; Chard T
    Am J Obstet Gynecol; 1983 Sep; 147(1):10-2. PubMed ID: 6604456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human placental lactogen: the watchdog of fetal distress.
    England P; Lorrimer D; Fergusson JC; Moffatt AM; Kelly AM
    Lancet; 1974 Jan; 1(7845):5-6. PubMed ID: 4129026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biparietal measurements, human placental lactogenic hormone and estradiol in the evaluation of the fetus].
    Berendtsen H; Klünder KB; Nørskov O
    Ugeskr Laeger; 1985 Sep; 147(38):2984-6. PubMed ID: 3907070
    [No Abstract]   [Full Text] [Related]  

  • 9. [Human placental lactogen determination as one of hormonal parameters in the evaluation of high risk pregnancy in its 3d trimester].
    Lukasik J; Rudzinski J; Wojcikowski C; Kusiak E; Wozniczko J; Emerich J; Stanlinska T
    Ginekol Pol; 1975 Feb; 46(2):129-35. PubMed ID: 1111253
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal assessment in late pregnancy: a current review.
    Biggs JS
    Aust N Z J Obstet Gynaecol; 1973 Nov; 13(4):202-5. PubMed ID: 4532537
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficiency of human placental lactogen and alpha-fetoprotein measurement in twin pregnancy detection.
    Knight GJ; Kloza EM; Smith DE; Haddow JE
    Am J Obstet Gynecol; 1981 Nov; 141(5):585-6. PubMed ID: 6170227
    [No Abstract]   [Full Text] [Related]  

  • 12. The fetus at risk.
    Chard T
    Lancet; 1974 Oct; 2(7885):880-3. PubMed ID: 4137976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of composite scoring of biochemical monitoring in fetal distress].
    Zhu FQ
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):136-9, 187. PubMed ID: 1874054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetal growth studied by echographic evaluation and by placental lactogen and estradiol levels].
    De Marchi C; Santi F; Zauli F; Roberti L; Perolo F
    Riv Ital Ginecol; 1977; 58(4):287-93. PubMed ID: 756599
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of antenatal tests of fetal welfare.
    Morrison J; Chang A; Keeping JD; Kilvert G
    Aust Fam Physician; 1982 Feb; 11(2):88-93. PubMed ID: 7073620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Ultrasonic diagnosis in cases of normal and pathologic pregnancy in comparison with endocrinologic parameters].
    Hansmann M; Patt V; Leyendecker G; Bellmann O; Hamacher M; Nocke W
    Arch Gynakol; 1973 Sep; 214(1):191-4. PubMed ID: 4801424
    [No Abstract]   [Full Text] [Related]  

  • 17. Human placental lactogen in evaluation of high risk pregnancies.
    Washington E
    J Med Soc N J; 1974 Aug; 71(8):585-8. PubMed ID: 4527829
    [No Abstract]   [Full Text] [Related]  

  • 18. Antepartum evaluation of the high-risk fetus: problems and prospects.
    Fabro S
    Environ Health Perspect; 1976 Dec; 18():67-72. PubMed ID: 71231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental lactogen levels as a screening test for fetal distress and neonatal asphyxia.
    Letchworth AT; Chard T
    Lancet; 1972 Apr; 1(7753):704-6. PubMed ID: 4111190
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Fetoplacental function tests.
    Lancet; 1973 Nov; 2(7837):1092-3. PubMed ID: 4127355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.